Nasal Vaccine May Be Effective for SPMS
A study in a mouse model of secondary progressive multiple sclerosis suggests that a nasal vaccine that regulates innate immunity may halt clinical disease and neurodegeneration
A study in a mouse model of secondary progressive multiple sclerosis suggests that a nasal vaccine that regulates innate immunity may halt clinical disease and neurodegeneration
Most multiple sclerosis patients are initially diagnosed with the relapsing-remitting form of the disease, but over time...
Laboratory Research, Meetings